Autopsy report · NCT05839509
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
Cause of deathSlow enrollment
“Recruitment of this patient population was more challenging than anticipated. The sponsor concluded that a sufficient amount of patients have completed the trial to demonstrate proof of concept in this patient population.”
Life of this trial
- Ran for about 1 year 8 months before it stopped.
- 6 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- GH Research Ireland Limited
- Sponsor type
- Industry
- Conditions
- Bipolar II Disorder
- Interventions
- GH001
- Participants
- 6
- Sites
- 7
- Countries
- Germany, Netherlands, United Kingdom
Trials that died the same way
- Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers
“clinical trial have encountered difficulties enrolling a sufficient number of patients” - TuLip : Role of the Tumor Environment in Cancer-related Fat Loss
“Limited number of recruited patients” - Pleural Suction Additional to Thoracostomy Tube for Traumatic Hemothorax
“It was not possible to achieve adequate recruitment to complete the necessary sample. The rate at which patients are recruited does not allow for continued participation” - Effect of Citalopram on Chest Pain in Patients With Functional Chest Pain
“The clinical trial has ended prematurely due to low patient recruitment” - Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal Insufficiency
“Insufficient recruitment of suitable patients.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.